Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 3 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHOMER, ISAAC | 2 | 63.2% | +30.3% |
| SCHLIENTZ, NATHAN W | 1 | 41.3% | -18.9% |
| GULLEDGE, BRIAN M | 1 | 55.7% | +26.2% |
| CARR, DEBORAH D | 1 | 81.8% | +2.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700022 | NITROGEN-CONTAINING CATIONIC LIPID AND APPLICATION THEREOF | CARR, DEBORAH D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18879062 | A METHOD FOR PREPARING A POLYETHYLENE GLYCOL ALDEHYDE DERIVATIVE | SCHLIENTZ, NATHAN W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18839059 | NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF | GULLEDGE, BRIAN M | — |
| 18284762 | PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF | SHOMER, ISAAC | — |
| 18284740 | PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF | SHOMER, ISAAC | — |
| Art Unit | Apps |
|---|---|
| 1612 | 2 |
| 1699 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18879062 | A METHOD FOR PREPARING A POLYETHYLENE GLYCOL ALDEHYDE DERIVATIVE | SCHLIENTZ, NATHAN W | — | §103§112 | Non-Final OA | — | Pending | Dec 26, 2024 |
| 18839059 | NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF | GULLEDGE, BRIAN M | 1699 | §102 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18700022 | NITROGEN-CONTAINING CATIONIC LIPID AND APPLICATION THEREOF | CARR, DEBORAH D | 1691 | §112 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18284762 | PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF | SHOMER, ISAAC | 1612 | §102§103§112DP | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18284740 | PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF | SHOMER, ISAAC | 1612 | §103§112DPOther | Non-Final OA | — | Pending | Sep 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial